Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity

We report a nanoparticle formulation of the SHH-pathway inhibitor vismodegib that improves efficacy for medulloblastoma, while reducing toxicity. Limited blood–brain barrier (BBB) penetration and dose-limiting extraneural toxicities complicate systemic therapies for brain tumors. Vismodegib is FDA-a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Nanomedicine
Egile Nagusiak: Hwang, Duhyeong, Dismuke, Taylor, Tikunov, Andrey, Rosen, Elias P., Kagel, John R., Ramsey, Jacob D., Lim, Chaemin, Zamboni, William, Kabanov, Alexander V., Gershon, Timothy R., Sokolsky-Papkov, Marina
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8160025/
https://ncbi.nlm.nih.gov/pubmed/33259959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2020.102345
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak